Trials / Completed
CompletedNCT02850978
Long-term Use of Spiolto Respimat in Japanese Patients With Chronic Obstructive Pulmonary Disease
Post-marketing Surveillance (PMS) on Long-term Use of Tiotropium+Olodaterol Fixed Dose Combination (Tio+Olo FDC) 5µg/5µg in Patients With Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema) in Japan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,335 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
Study to assess the long-term safety and effectiveness of Spiolto in Japanese patients with Chronic Obstructive Pulmonary Disease (COPD) in real-world setting
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Spiolto |
Timeline
- Start date
- 2016-08-23
- Primary completion
- 2018-10-30
- Completion
- 2018-11-30
- First posted
- 2016-08-01
- Last updated
- 2019-12-06
- Results posted
- 2019-12-06
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02850978. Inclusion in this directory is not an endorsement.